Please assess the completion status of the following clinical trial:

Trial Title: Treating Pyelonephritis an Urosepsis With Pivmecillinam

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* E.coli in blood culture~* AND identical isolate in urine sample (\>= 1.000 CFU) OR relevant clinical signs of UTI~Exclusion Criteria:~* Bacterial infection origin from another organ (e.g. pneumonia)~* Severe sepsis with multiorgan failure~* Perinephritic abscess~* Pyonephrosis requiring drainage~* Allergy to pivmecillinam~* E.coli isolate resistant to pivmecillinam~* Pregnancy/breastfeeding~* Severe neutropenia~* Prostatitis~* Severe kidney failure (eGFR\<15 ml/min)~* Using valproate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 110 Years
- Healthy Volunteers: f

Study Arms:
- Pivmecillinam (Type: EXPERIMENTAL): Patients treated with pivmecillinam

Based on this trial design, predict the completion outcome and termination type (if applicable).